Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05846932 · ClinicalTrials.gov registry record · NA

Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism

A NA study, sponsored by Colorado State University.

Completed
Registry status
NA
Development phase
73
Enrollment target

NCT05846932: Completed NA study, sponsored by Colorado State University.

NCT05846932 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 73 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05846932, a NA study, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
NA
Development phase
73 participants
Enrollment target

Study Summary

The goal of this clinical trial is to learn about occupational therapy integrating horses for autistic youth. The main questions it aims to answer are: * Does occupational therapy integrating horses improve self-regulation in autistic youth * Does occupational therapy integrating horses affect salivary cortisol and alpha-amylase Participants will receive 10 weeks of occupational therapy, and will be asked to provide saliva samples each week. Researchers will compare occupational therapy integrating horses to occupational therapy in a clinic to see if integrating horses affects self-regulation.

Primary Outcome

Parent-report checklist of problematic behaviors related to hyperactivity and irritability

Interventions

  • BEHAVIORAL OTEE HORS
  • BEHAVIORAL OT Clinic

Trial Details

FieldValue
Enrollment Target 73 participants
Start Date 2023-03-21
Est. Completion 2025-11-01
Phase NA
Colorado State University

94 total trials

What the finished NCT05846932 record still lists

NCT05846932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 73 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which OTEE HORS is the first listed.

NCT05846932 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05846932 about?

NCT05846932 is a clinical study titled "Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism". The goal of this clinical trial is to learn about occupational therapy integrating horses for autistic youth. The main questions it aims to answer are: * Does occupational therapy integrating horses improve self-regulation in autistic youth * Does occupational therapy integrating horses affect sali...

What is the current status of trial NCT05846932?

This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2023-03-21. Estimated completion is 2025-11-01.

What interventions are being tested in trial NCT05846932?

The interventions under investigation include: OTEE HORS (BEHAVIORAL), OT Clinic (BEHAVIORAL).

Who is sponsoring clinical trial NCT05846932?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05846932's enrollment target sits among peer trials

73 1089th of 2000 higher than 912 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03661307 · 73 participants · Phase 1

    Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

  • NCT05386108 · 73 participants · Phase 1

    Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

  • NCT05961592 · 73 participants · Phase 1

    R-2487 in Patients With Rheumatoid Arthritis

  • NCT06150664 · 73 participants · Phase 1

    A Phase 1 of CTX-8371 in Patients With Advanced Malignancies

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05846932, the US trial registry maintained by the National Library of Medicine. NCT05846932 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.